Page 24 - Roche Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Country and Growth Forecast, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.The Asia Pacific Non Hodgkin Lymphoma Therapeutics Market would witness market growth of 9.3% CAGR during the forecast period

Technological advancements in drug development are offering lucrative horseradish peroxidase market opportunities to companies operating in this sector....

Technological advancements in drug development are offering lucrative horseradish peroxidase market opportunities to companies operating in this sector.Wilmington, Delaware, United States, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global market for horseradish peroxidase is anticipated to attain a valuation of US$ 100 million by 2031. As per TMR’s findings, the industry is expected to demonstrate substantial growth, with an expected CAGR of 7.3%. Horseradish perox

AIM ImmunoTech (NYSE:AIM – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations. Earnings & Valuation This table compares AIM […]

Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Valuation and Earnings This table compares Poseida […]